TY - JOUR T1 - Interpretation of mendelian randomization using one measure of an exposure that varies over time JF - medRxiv DO - 10.1101/2021.11.18.21266515 SP - 2021.11.18.21266515 AU - Tim T Morris AU - Jon Heron AU - Eleanor Sanderson AU - George Davey Smith AU - Kate Tilling Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/29/2021.11.18.21266515.abstract N2 - Background Mendelian randomization (MR) is a powerful tool through which the causal effects of modifiable exposures on outcomes can be estimated from observational data. Most exposures vary throughout the life course, but MR is commonly applied to one measurement of an exposure (e.g., weight measured once between ages 40 and 60). It has been argued that MR provides biased causal effect estimates when applied to one measure of an exposure that varies over time.Methods We propose an approach that emphasises the liability that causes the entire exposure trajectory. We demonstrate this approach using simulations and an applied example.Results We show that rather than estimating the direct or total causal effect of changing the exposure value at a given time, MR estimates the causal effect of changing the liability as induced by a specific genotype that gives rise to the exposure at that time. As such, results from MR conducted at different time points are expected to differ (unless the liability of exposure is constant over time), as we demonstrate by estimating the effect of BMI measured at different ages on systolic blood pressure.Conclusions Practitioners should not interpret MR results as timepoint-specific direct or total causal effects, but as the effect of changing the liability that causes the entire exposure trajectory. Estimates of how the effects of a genetic variant on an exposure vary over time are needed to interpret timepoint-specific causal effects.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAll authors are part of the MRC Integrative Epidemiology Unit (IEU) at the University of Bristol, which is supported by the MRC (MC_UU_00011/5 and MC_UU_00011/3).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This manuscript uses summary data from two studies; 1: Hardy, R. et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum. Mol. Genet. 19 (2010). 2: Timpson, N. J. et al. Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO/MC4R genotype. Hypertension 54 (2009).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll summary data used and code for producing the analyses are available at https://github.com/timtmorris/time-varying-MR. ER -